| Treatment of neuropathy in Soest |
Innovative treatment of neuropathy and neuropathic painWelcome to our expertise centre for the treatment of neuropathy and neuropathic pain. And for the consultation of innovative porgrammes for novel drugs and transdermal applications to treat neuropathic pain. In our clinic we are specialized in treating patients suffering from neuropathic pain, and we look for the best effective treatments, without troublesome side-effects. There are many centers in the Netherlands where expertise exists in making the diagnosis of neuropathy. But treatment remains a difficult issue. As well as the science behind developing new drugs, a difficult issue too. In our institute we are focussed on the selection and the exploration of useful, safe and effective treatments! And on provding acurate and up to date information related to neuropathy and neuropathic pain.
Because people with neuropathy and neuropathic pain are too often told: "You must learn to live with me." And you are not always sufficiently treated.[1] [2] [3] [4] And that is quite shocking. For more than 90% of patients with neuropathic pain in our own country is not treated properly![5] And the quality of life is very low, even when patients use painkillers! [6][7] Scientific basis and centre for Integrated MedicineWe always opt for treatments that are effective and are safe and have a scientific basis. We also watch out that these operations in addition to the usual forms of therapy can be given without any problems. This site contains thousands of references to modern literature studies show that a meaningful treatment of neuropathy and neuropathic pain is actually possible. We have all of these studies collected for fellow physicians and our patients who want to understand why we treat as we do. In more than 500 articles at this website! www.neuropathie.nu This is the largest website in the Netherlands in the field of Integrated Medicine (integrated medicine). With many practical tips and scientific facts. How we treatFor each patient with a neuropathy or neuropathic pain, we have developed a treatment protocol. If you decide to be treated in our centre, we need at least to treat you once a week for 10 weeks. What is chronic, such as neuropathy, can not change quickly, so we have time. The pain usually responds after the first few weeks or sometimes faster. After we determine together how to proceed. Usually we go every 2 weeks treatment, then every three weeks, then once a month until we have reached a stable situation. We pursue a variety of techniques, from modern iontophoresis, percutaneous electrical stimulation on the needle electrodes to the application of our innovative neuropathic pain creams. And to continue to be of service to you with this site, we have compiled to give you access to all information in the field of neuropathy and pain. Together with you we decide what an appropriate treatment for you. Our centre helping pharmaceutical industry in research and developmentFurthermore, due to the fact that we have many years experience in advising life science investors and pharmaceutical companies, we also assist in programmes for the development of new drugs within the field of neuropathy and neuropathic pain. One of the founders of the centre for neuropathy, professor Jan M. Keppel Hesselink, was elected as FFPM (Fellow of the Faculty of Pharmaceutical Medicine (London) due to his innovative work as a VP of Bayer AG in the field of R&D of CNS drugs. He and his team can be asked for consultation if new drugs and transdermal applications are tested for the treatment of neuropathic pain. March 2010; Prof.dr. Jan M. Keppel Hesselink, MD, PhD en Drs David J. Kopsky, MD Referenties[1]: Oster G, Berger A, Dukes E, Edelsberg J, McCarberg B. | Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. | Am J Geriatr Pharmacother. | 2004 Sep;2(3):163-70. [2]: Gore M, Dukes E, Rowbotham DJ, Tai KS, Leslie D. | Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. | Eur J Pain. | 2007 Aug;11(6):652-64. Epub 2006 Nov 27. [3]: Lachaine J, Gordon A, Choinière M, Collet JP, Dion D, Tarride JE. | Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database. | Pain Res Manag. | 2007 Spring;12(1):31-7. [4]: Berger A, Toelle T, Sadosky A, Dukes E, Edelsberg J, Oster G. | Clinical and economic characteristics of patients with painful neuropathic disorders in Germany. | Pain Pract. | 2009 Jan-Feb;9(1):8-17. Epub 2008 Oct 8. [5]: Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. | Incidence rates and treatment of neuropathic pain conditions in the general population. | Pain. | 2008 Jul 31;137(3):681-8. Epub 2008 Apr 24. [6]: O'Connor AB. | Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. | Pharmacoeconomics. | 2009;27(2):95-112. doi: 10.2165/00019053-200927020-00002. [7]: Hoffman DL, Sadosky A, Alvir J. | Cross-national burden of painful diabetic peripheral neuropathy in Asia, Latin America, and the Middle East. | Pain Pract. | 2009 Jan-Feb;9(1):35-42. Epub 2008 Oct 27. |